Literature DB >> 27349307

Indication of Ventricular Assist Device Therapy in Patients with INTERMACS Profile 4-7.

Teruhiko Imamura1, Koichiro Kinugawa.   

Abstract

Optimal timing of ventricular assist device (VAD) therapy has been discussed mainly among patients with heart failure dependent on inotrope infusion, but little is known about the indication of VAD therapy among less sick ambulatory patients. Considering recent improvement of VAD therapy outcome, now is the best time to discuss the expansion of VAD indication into less sick population. In this review, we will investigate optimal candidates for VAD therapy especially among ambulatory populations on the basis of recent evidence.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27349307      PMCID： PMC5088391          DOI： 10.5761/atcs.ed.16-00119

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN： 1341-1098            Impact factor:   1.520


  14 in total

1.  The Registry Report of Heart Transplantation in Japan (1999-2014).

Authors:  Takeshi Nakatani; Norihide Fukushima; Minoru Ono; Yoshikatsu Saiki; Hikaru Matsuda; Shinichi Nunoda; Yoshiki Sawa; Mitsuaki Isobe
Journal:  Circ J       Date:  2015-12-04       Impact factor: 2.993

2.  ISHLT International Registry for Heart and Lung Transplantation--into the fourth decade, from strength to strength.

Authors:  Josef Stehlik; Jeffrey D Hosenpud; Leah B Edwards; Marshall I Hertz; Mandeep R Mehra
Journal:  J Heart Lung Transplant       Date:  2013-10       Impact factor: 10.247

3.  Should cardiac resynchronization therapy be a rescue therapy for inotrope-dependent patients with advanced heart failure?

Authors:  Teruhiko Imamura; Koichiro Kinugawa; Daisuke Nitta; Masaru Hatano; Issei Komuro
Journal:  J Card Fail       Date:  2015-04-27       Impact factor: 5.712

4.  Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: Results From the ROADMAP Study.

Authors:  Jerry D Estep; Randall C Starling; Douglas A Horstmanshof; Carmelo A Milano; Craig H Selzman; Keyur B Shah; Matthias Loebe; Nader Moazami; James W Long; Josef Stehlik; Vigneshwar Kasirajan; Donald C Haas; John B O'Connell; Andrew J Boyle; David J Farrar; Joseph G Rogers
Journal:  J Am Coll Cardiol       Date:  2015-10-20       Impact factor: 24.094

5.  Complete left bundle branch block and smaller left atrium are predictors of response to cardiac resynchronization therapy in advanced heart failure.

Authors:  Teruhiko Imamura; Koichiro Kinugawa; Daisuke Nitta; Issei Komuro
Journal:  Circ J       Date:  2015-09-17       Impact factor: 2.993

6.  Novel scoring system using cardiopulmonary exercise testing predicts prognosis in heart failure patients receiving guideline-directed medical therapy.

Authors:  Teruhiko Imamura; Koichiro Kinugawa; Daisuke Nitta; Toshiro Inaba; Hisataka Maki; Masaru Hatano; Issei Komuro
Journal:  Circ J       Date:  2015-02-16       Impact factor: 2.993

7.  Late-onset right ventricular failure in patients with preoperative small left ventricle after implantation of continuous flow left ventricular assist device.

Authors:  Teruhiko Imamura; Koichiro Kinugawa; Naoko Kato; Hironori Muraoka; Takeo Fujino; Toshiro Inaba; Hisataka Maki; Osamu Kinoshita; Masaru Hatano; Shunei Kyo; Minoru Ono
Journal:  Circ J       Date:  2014-01-16       Impact factor: 2.993

8.  The Seattle Heart Failure Model: prediction of survival in heart failure.

Authors:  Wayne C Levy; Dariush Mozaffarian; David T Linker; Santosh C Sutradhar; Stefan D Anker; Anne B Cropp; Inder Anand; Aldo Maggioni; Paul Burton; Mark D Sullivan; Bertram Pitt; Philip A Poole-Wilson; Douglas L Mann; Milton Packer
Journal:  Circulation       Date:  2006-03-13       Impact factor: 29.690

9.  Post-approval study of a highly pulsed, low-shear-rate, continuous-flow, left ventricular assist device, EVAHEART: a Japanese multicenter study using J-MACS.

Authors:  Satoshi Saito; Kenji Yamazaki; Tomohiro Nishinaka; Yuki Ichihara; Minoru Ono; Syunei Kyo; Takashi Nishimura; Takeshi Nakatani; Koichi Toda; Yoshiki Sawa; Ryuji Tominaga; Tadahisa Tanoue; Yoshikatsu Saiki; Yoshiro Matsui; Takahiro Takemura; Hiroshi Niinami; Goro Matsumiya
Journal:  J Heart Lung Transplant       Date:  2014-03-04       Impact factor: 10.247

10.  Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score.

Authors:  Jennifer Cowger; Kartik Sundareswaran; Joseph G Rogers; Soon J Park; Francis D Pagani; Geetha Bhat; Brian Jaski; David J Farrar; Mark S Slaughter
Journal:  J Am Coll Cardiol       Date:  2012-12-19       Impact factor: 24.094
View more
  1 in total

1.  Gastrointestinal Bleeding as a Complication in Continuous Flow Ventricular Assist Devices: A Systematic Review With Meta-Analysis.

Authors:  Edinen Asuka; Stella Pak; Armond-Kristopher Thiess; Anthony Torres
Journal:  J Clin Med Res       Date:  2020-08-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.